By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kinex Pharmaceuticals 

1207 Delaware Avenue

Buffalo  New York  14209  U.S.A.
Phone: 716-332-6107 Fax: 716-332-6170


Company News
Hanmi Pharmaceutical, Co., Ltd To Assign The Rights Of The Indian Territory To Kinex Pharmaceuticals As Part Of The Orascovery Program Strategic Plan 3/9/2015 10:48:36 AM
Particle Sciences Manufactures Clinical Supplies For Kinex Pharmaceuticals's Glioblastoma Therapeutic 2/18/2015 2:27:39 PM
Kinex Pharmaceuticals Licenses Patents From Hong Kong Polytechnic University 2/13/2015 9:34:24 AM
Kinex Pharmaceuticals Announces First Patient Dosed With KX2-391 Ointment For Actinic Keratosis In A Phase 1 Clinical Study 1/20/2015 6:46:15 AM
Kinex Pharmaceuticals Announces First Patient Dosed With KX2-361 In A Phase 1 Clinical Study 12/24/2014 7:29:31 AM
Kinex Pharmaceuticals Appoints Chief Operating Officer 12/17/2014 9:12:10 AM
Hanmi Pharmaceutical, Co., Ltd And Collaborative Partner Kinex Pharmaceuticals Announce Preliminary Results From A Phase I Clinical Study (HM-OTE-103) With Oratecan® In Patients With Advanced Cancer 10/15/2014 7:56:26 AM
Kinex Pharmaceuticals Completes Acquisition Of QuaDPharma 9/9/2014 7:42:00 AM
Kinex Pharmaceuticals Announces Allowance Of The Investigational New Drug (IND) Application For KX2-391 Ointment By The United States FDA 7/24/2014 11:04:31 AM
Kinex Pharmaceuticals Appoints Mr. Michael Murphy To The Board Of Directors 7/1/2014 11:50:30 AM